CVS plans a pharmacy split as shares slide despite a higher outlook

A breakup plan lands alongside stronger earnings

CVS Health announced on November 4 that it intends to create two publicly traded companies. Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health would remain together under the interim CVS Health name. Approximately 9,000 pharmacies, mail pharmacy, MinuteClinic and Health100 would form CVS Pharmacy. These are proposed business boundaries, not an already completed transaction. [1]

The target is the first half of 2028. Shareholders would own both companies; the separation is intended to be tax-free for U.S. federal income-tax purposes, subject to conditions including final board approval and an effective Form 10 registration statement. Management’s argument is simpler structures and more focused capital allocation. That is an intended benefit, not a guaranteed valuation uplift. [1]

The earnings release covers the quarter ended September 30, 2026. Revenue was US$108.399 billion, versus US$102.871 billion a year earlier. GAAP diluted EPS was US$1.68, compared with a US$3.13 loss; adjusted EPS was US$2.09 versus US$1.60. Last year included a US$5.7 billion goodwill impairment, so the GAAP rebound is not all underlying growth. [2]

The market reaction is not an earnings-only verdict

Cboe’s saved delayed snapshot, retrieved at 11:08:37 ET, showed CVS at US$81.2925 against a US$91.41 previous close: down US$10.1175, or 11.07%. Its last stock trade was stamped 10:42:50 ET. Captured volume was 11,683,811 shares—1.35 times the preceding 20 completed sessions’ full-day average of 8,674,975. This is not a same-time volume comparison or a live quote. [3][7]

Peers did not show one uniform healthcare sell-off. Separate delayed Cboe observations showed UnitedHealth down 0.31% at 10:51:56 ET, Cigna up 2.66% at 10:50:32 and healthcare ETF XLV up 1.52% at 10:41:40. Those unsynchronized observations provide context, not proof that the separation caused every dollar of CVS’s decline. The restructuring adds execution questions to otherwise improving earnings. [1][3–6]

Where the operating improvement came from

Health Care Benefits adjusted operating income rose to US$912 million from US$314 million. Its medical benefit ratio fell to 91.3% from 92.8%, reflecting improved Government-business performance. Health Services adjusted operating income increased 2.7% to US$2.106 billion; Pharmacy & Consumer Wellness rose 10.6% to US$1.635 billion despite revenue declining 2.0%. Better profits do not mean every business is growing sales. [2]

The higher annual cash-flow floor matters, but it is guidance, not cash already guaranteed for the final quarter. CVS still cited elevated cost trends and potential macroeconomic headwinds. Meanwhile, the proposed pharmacy company must stand on its own economics, and the remaining group retains insurance and pharmacy-services exposure. A cleaner organization chart cannot by itself settle those risks. [1][2]

What it means for option sellers

Cboe displayed 30-day implied volatility of 32.124%, down 9.233 percentage points. A separate OptionCharts page captured at 11:10 ET displayed 32.95% IV and 42.19% IV rank, with options marked 15-minute delayed. The vendors and observation times differ; IV rank is not a probability of profit. These snapshots do not justify calling premiums unusually rich. [3][8]

For the wheel, the central question is the obligation behind the credit. A cash-secured put can become shares during a sharp decline; a later covered call limits upside without eliminating stock downside. Today’s scheduled earnings release is already out, but restructuring announcements and the next report can still reprice risk. The issuer calendar showed no upcoming event date, so no next-earnings date is certified here. [1][10–12]

• Reassess the underlying business before treating a lower share price as a bargain; assignment changes the exposure, not the business risks. [1][10]
• A management plan should distinguish closing risk, accepting assignment and considering a later covered call. None guarantees a loss recovery. [10][11]

What to watch next

• November 6, 08:30 ET: October U.S. employment report; November 10, 08:30 ET: October CPI. Both can shift the wider market before the illustrative November 20 expiry. [9]
• First half of 2028: management’s conditional separation target. Watch for the Form 10, capital structures and further company disclosures; no exact completion day is promised. [1]
• Next CVS earnings: unconfirmed on the checked issuer calendar. Recheck company dates before selecting an expiry or rolling exposure. [12]

Hero: archival May 29, 2024 CVS storefront in Solomons, Maryland, photographed by Harrison Keely, CC BY 4.0. Cropped and resized; not today’s news scene. No endorsement implied. [13][14]

For information and education, not personal financial advice. Options and shares can lose substantial value; examples exclude fees, taxes and slippage.